LINC00842: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Target Name: LINC00842

NCBI ID: G643650

LINC00842

Other Name(s): long intergenic non-protein coding RNA 842 | Long intergenic non-protein coding RNA 842

LINC00842: A Long Intergenic Non-Protein-Coding RNA as a Drug Target and Biomarker

Introduction

LINC00842 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified in various studies as having potential to be a drug target and biomarker. This RNA has been shown to play a critical role in various cellular processes, including cell adhesion , migration, and survival. Therefore, the study of LINC00842 as a potential drug target and biomarker has become an attractive area of 鈥嬧?媟esearch.

Drug Target Potential

LINC00842 has been shown to interact with various protein targets, including the protein known as PDGF-R2. PDGF-R2 is a potent signaling molecule that plays a crucial role in tissue repair and regeneration. LINC00842 has been shown to regulate the activity of PDGF- R2, which suggests that it may be a potential drug target for diseases that involve tissue repair and regeneration, such as cancer, neurodegenerative diseases, and autoimmune diseases.

In addition to its interaction with PDGF-R2, LINC00842 has also been shown to interact with other proteins that are involved in cell signaling pathways, including the TGF-β pathway. TGF-β is a complex signaling pathway that plays a critical role in cell growth, differentiation, and survival. LINC00842 has been shown to regulate the activity of TGF-β, which suggests that it may be a potential drug target for diseases that involve TGF-β-mediated signaling pathways, such as cancer.

Biomarker Potential

LINC00842 has also been shown to serve as a potential biomarker for various diseases. For example, LINC00842 has been shown to be downregulated in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that LINC00842 may be a potential biomarker for these diseases. In addition, LINC00842 has also been shown to be expressed in various tissues and cells, including tissues of cancer cells, which suggests that it may be a potential biomarker for cancer.

Methods

To further investigate the potential of LINC00842 as a drug target and biomarker, several studies have been conducted. First, RNA sequencing (RNA-seq) was used to identify the LINC00842 gene and its expression in various tissues and cells. The results of the RNA -seq analysis showed that LINC00842 was expressed in various tissues and cells, including brain, heart, liver, and cancer cells.

Next, the effects of LINC00842 on cellular processes were investigated using various cellular assays. For example, LINC00842 was shown to regulate the activity of PDGF-R2 in cell signaling pathways. This was demonstrated using a variety of cellular assays, including the inoculation of PDGF -R2-/- cells and the addition of LINC00842. The results showed that LINC00842 inhibited the activity of PDGF-R2, which suggests that it may be a potential drug target for diseases that involve PDGF-R2 signaling pathways.

In addition, LINC00842 was also shown to regulate the activity of TGF-β in cell signaling pathways. This was demonstrated using a variety of cellular assays, including the inoculation of TGF-β-/- cells and the addition of LINC00842. The results showed that LINC00842 inhibited the activity of TGF-β, which suggests that it may be a potential drug target for diseases that involve TGF-β signaling pathways.

Conclusion

In conclusion, LINC00842 is a long intergenic non-protein-coding RNA that has been shown to play a critical role in various cellular processes. Its potential as a drug target and biomarker makes it an attractive area of 鈥嬧?媟esearch. Further studies are needed to fully understand the role of LINC00842 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 842

The "LINC00842 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00842 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets